FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and describes a combination of tetrahydrocannabinol (THC) and cannabidiole (CBD) cannabinoids in ratio 1:5 for preparing a drug applicable in treating glioma, wherein the cannabinoid concentration falls within the range of 5 to 100 mg of the total cannabinoid concentration, wherein treating glioma involves reducing the cell survival rate, suppressing the cell growth and reducing the tumour volume.
EFFECT: invention provides increasing the efficacy of cannabinoids in a combination of THC and CBD in treating glioma.
5 cl, 5 ex, 2 tbl, 6 dwg
Authors
Dates
2015-04-10—Published
2009-06-04—Filed